Showing results (71-80 of 1,316) with videos related to

Sort By:
Pageof 132
Expert Review of Cardiovascular Therapy|October 4, 2012
Coronary heart disease in type 2 diabetes: mechanisms and comprehensive prevention strategiesYabin Wang, Qiujun Yu, Daiming Fan, et al.
Oncogene|April 5, 2025
Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancerShuyi Chen, Tingyu Li, Dan Liu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 30, 2014
Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis of observational studiesXingshun Qi, Zhiping Yang, Valerio De Stefano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 6, 2014
Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysisXingshun Qi, Weirong Ren, Valerio De Stefano, et al.
Oncogene|March 1, 2020
SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-METFeng Du, Xiaowei Li, Weibo Feng, et al.
Cell Death & Disease|March 13, 2019
SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesisFeng Du, Jie Chen, Hao Liu, et al.
The Journal of Biological Chemistry|July 3, 2024
miR-107 reverses the multidrug resistance of gastric cancer by targeting the CGA/EGFR/GATA2 positive feedback circuitPei Wang, Yelu Zhou, Juan Wang, et al.
FEBS Open Bio|February 14, 2018
miR-204-5p suppresses hepatocellular cancer proliferation by regulating homeoprotein SIX1 expressionYi Chu, Mingzuo Jiang, Feng Du, et al.
Zhonghua Nei Ke Za Zhi|November 8, 2002
[Antisense inhibition of cyclooxygenase-2 reduces malignant phenotype of gastric cancer cells]Hanping Wu, Kaichun Wu, Liping Yao, et al.
Cancer Biology & Therapy|November 26, 2008
RNAi-mediated inhibition of Raf-1 leads to decreased angiogenesis and tumor growth in gastric cancerFanping Meng, Baoxia Dong, Hanwei Li, et al.
Pageof 132